Guo YL et al. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma. J Biomed Sci24:6 (2017).
Read more (PubMed: 28077137) »
Hou J et al. DACT2 is a candidate tumor suppressor and prognostic marker in esophageal squamous cell carcinoma. Cancer Prev Res (Phila)6:791-800 (2013).
Read more (PubMed: 23803417) »